We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$644B
$3.05M 0.91%
28,357
+1,532
+6% +$179K
TXN icon
27
Texas Instruments
TXN
$252B
$3.04M 0.91%
16,239
+233
+1% +$46.6K
LHX icon
28
L3Harris
LHX
$51.6B
$3.04M 0.91%
14,435
-150
-1% -$35.9K
COST icon
29
Costco
COST
$422B
$3.02M 0.9%
3,293
-30
-0.9% -$27.8K
V icon
30
Visa
V
$684B
$2.75M 0.82%
8,705
+343
+4% +$103K
MRSH
31
Marsh
MRSH
$90.5B
$2.72M 0.81%
12,784
ECL icon
32
Ecolab
ECL
$78.1B
$2.69M 0.8%
11,499
-461
-4% -$115K
WPC icon
33
W.P. Carey
WPC
$16.8B
$2.65M 0.79%
48,641
+1,535
+3% +$87.5K
NVDA icon
34
NVIDIA
NVDA
$4.86T
$2.6M 0.78%
19,395
+1,420
+8% +$196K
ARCC icon
35
Ares Capital
ARCC
$13.5B
$2.54M 0.76%
116,200
+14,775
+15% +$319K
LLY icon
36
Eli Lilly
LLY
$1.02T
$2.53M 0.76%
3,278
+1,234
+60% +$1.02M
CMI icon
37
Cummins
CMI
$87.5B
$2.5M 0.74%
7,160
SYK icon
38
Stryker
SYK
$125B
$2.36M 0.71%
6,568
+182
+3% +$67.4K
VRT icon
39
Vertiv
VRT
$93B
$2.34M 0.7%
20,575
+1,225
+6% +$145K
PANW icon
40
Palo Alto Networks
PANW
$270B
$2.3M 0.69%
12,648
+870
+7% +$164K
MINT icon
41
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$2.11M 0.63%
21,023
+962
+5% +$96.7K
CVX icon
42
Chevron
CVX
$392B
$2.03M 0.61%
14,014
+389
+3% +$59.5K
XLI icon
43
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$2M 0.6%
15,192
SYY icon
44
Sysco
SYY
$40.8B
$1.97M 0.59%
25,768
-855
-3% -$65.5K
CL icon
45
Colgate-Palmolive
CL
$73.1B
$1.87M 0.56%
20,559
-350
-2% -$33.4K
JNJ icon
46
Johnson & Johnson
JNJ
$618B
$1.82M 0.54%
12,584
-971
-7% -$150K
DE icon
47
Deere & Co
DE
$160B
$1.82M 0.54%
4,288
+2
+0% +$842
IWF icon
48
iShares Russell 1000 Growth ETF
IWF
$121B
$1.8M 0.54%
17,900
CRM icon
49
Salesforce
CRM
$151B
$1.78M 0.53%
5,328
+174
+3% +$55.5K
RTX icon
50
RTX Corp
RTX
$290B
$1.71M 0.51%
14,800
+1,312
+10% +$159K

Similar funds

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.